|
Volumn 22, Issue 10, 2009, Pages 68-77
|
Biopharmaceuticals: Approval Trends in 2008
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACCRETROPIN;
CERTOLIZUMAB PEGOL;
EXTAVIA;
HUMAN GROWTH HORMONE;
INSULIN ASPART;
NOVOLOG MIX;
PEGINTRON RIBETOL;
PLACEBO;
RECOMBINANT BLOOD CLOTTING FACTOR 8;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RECOMBINANT GROWTH HORMONE;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
RECOMBINANT PROTEIN;
RECOTHROM;
RILONACEPT;
ROMIPLOSTIM;
THROMBIN;
UNCLASSIFIED DRUG;
ARTHRALGIA;
BLEEDING;
CINCA SYNDROME;
CLINICAL TRIAL;
CROHN DISEASE;
DIZZINESS;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG INDICATION;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SCREENING;
EUROPEAN UNION;
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME;
GROWTH DISORDER;
GROWTH HORMONE DEFICIENCY;
HUMAN;
IDIOPATHIC THROMBOCYTOPENIC PURPURA;
INJECTION SITE CONTUSION;
INJECTION SITE EDEMA;
INJECTION SITE ERYTHEMA;
INJECTION SITE REACTION;
INSOMNIA;
MUCKLE WELLS SYNDROME;
MYCOSIS;
NEUTROPENIA;
OPPORTUNISTIC INFECTION;
RHEUMATOID ARTHRITIS;
SHORT STATURE;
SHORT SURVEY;
SHOULDER PAIN;
STOMACH PAIN;
THROMBOCYTOPENIA;
TREND STUDY;
TUBERCULOSIS;
TURNER SYNDROME;
UNITED STATES;
UNSPECIFIED SIDE EFFECT;
|
EID: 77951632179
PISSN: 1542166X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (4)
|
References (6)
|